Skip to main content
UniHealth

Doctor search

Lydia Lee Chou, NP

Nurse Practitioner · Stanford

NPI 1679914501

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Lydia Lee Chou’s office at (650) 723-4000 to ask if they take your plan before you enroll.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$1,745,029

Medicare paid this office $1,745,029 for 214 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Injection, pembrolizumab, 1 mg16$426,488None
Injection, denosumab, 1 mg34$92,981None
Injection, darbepoetin alfa, 1 microgram (non-esrd use)16$38,091None
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg17$28,499None
Return visit (30+ min)125$25,649$101
See all 22 services
Every Original Medicare service billed
Injection, pembrolizumab, 1 mg16$426,488None
Injection, denosumab, 1 mg34$92,981None
Injection, darbepoetin alfa, 1 microgram (non-esrd use)16$38,091None
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg17$28,499None
Return visit (30+ min)125$25,649$101
Administration of chemotherapy into vein, 1 hour or less59$23,261$119
Administration of additional new drug or substance into vein, 1 hour or less20$5,110$58
Injection of additional new drug or substance into vein46$5,002$14
Long return visit (40+ min)28$4,798$130
Injection of drug or substance under skin or into muscle62$2,115$12
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle12$1,710$32
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count86$1,545$8
Short return visit (20+ min)11$1,498$75
Administration of chemotherapy into vein, each additional hour17$1,490$24
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less15$1,364$57
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less17$1,341$25
Injection, palonosetron hcl, 25 mcg29$840None
Injection, carboplatin, 50 mg13$798None
Application of on-body injector for under skin injection17$605$16
Injection, fosaprepitant, 1 mg14$477None
Injection, dexamethasone sodium phosphate, 1 mg35$137None
Injection, diphenhydramine hcl, up to 50 mg29$52None

Who their Medicare patients are

214 Original Medicare patients in 2024. Average age 75 · Under 65 8% · 85 and older 17% · Women 70% · Also on Medicaid 20% · Health risk score 2.49. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 75% · Cancer 64% · Chronic kidney disease 45% · Diabetes 29% · Coronary heart disease 29% · COPD 24% · Depression 24% · Heart failure 22% · Atrial fibrillation 20% · Stroke 7%.

The office billed $8,445,557, Medicare allowed $2,194,995 and paid $1,745,029; for 110,140 services of 102 kinds; $1,658,979 of it was for drugs given in the office and $86,050 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024214110,140752.49$8,445,557$1,745,029
20232017,000752.09$611,862$129,784
20224458742.16$20,012$5,293
20141392710.58$14,962$4,400

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 8 services

Original Medicare services billed in 2023
Short return visit (20+ min)139$14,028$61
Return visit (30+ min)35$2,581$68
Administration of chemotherapy into vein, 1 hour or less14$1,632$117
New patient visit (30+ min)12$933$78
Injection of additional new drug or substance into vein15$441$13
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count20$152$8
Injection of drug or substance under skin or into muscle11$129$12
Injection, dexamethasone sodium phosphate, 1 mg11$11None

2022: 1 service

Original Medicare services billed in 2022
Return visit (30+ min)44$5,135$93

Drugs they prescribed that Part D paid

$2,361,415

Pharmacies billed $2,361,415 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 3% of their Part D prescriptions (26 of 829) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.

615 generic and 214 brand-name prescriptions · $2,361,415 in drug cost · 12 antibiotic prescriptions.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Ibrance23$411,512$17,892
Tagrisso23$376,915$16,388
Revlimid16$297,261$18,579
Lenalidomide15$200,096$13,340
Xtandi13$172,413$13,263
See all 23 drugs
Every Part D drug this clinician prescribed
Ibrance23$411,512$17,892
Tagrisso23$376,915$16,388
Revlimid16$297,261$18,579
Lenalidomide15$200,096$13,340
Xtandi13$172,413$13,263
Everolimus17$59,650$3,509
Eliquis41$32,644$796
Xarelto28$25,512$911
Anastrozole70$2,017$29
Hydroxyurea26$1,381$53
Exemestane13$989$76
Letrozole31$876$28
Acyclovir23$649$28
Tamoxifen Citrate16$462$29
Alendronate41$338$8
Potassium Chloride12$280$23
Gabapentin42$246$6
Dexamethasone17$242$14
Levothyroxine18$223$12
Ondansetron16$218$14
Prochlorperazine Maleate24$216$9
Lorazepam26$194$7
Prednisone15$61$4

Year by year

Part D prescribing by year
20248292263% (26)26%$2,361,415
20233591183% (12)None$154,064
202233210% (0)None$16,122
201711643None26%$319,222
20163431039% (31)36%$988,276
2015244817% (17)24%$357,063
20142013NoneNone$222

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 7 drugs

Part D drugs prescribed in 2023
Eliquis15$13,537$902
Acyclovir41$1,285$31
Fluconazole12$1,092$91
Hydroxyurea31$742$24
Gabapentin24$514$21
Dexamethasone17$342$20
Prednisone15$158$11

2017: 2 drugs

Part D drugs prescribed in 2017
Hydroxyurea15$534$36
Letrozole12$86$7

2016: 6 drugs

Part D drugs prescribed in 2016
Jakafi15$238,658$15,911
Revlimid18$158,164$8,787
Hydroxyurea16$433$27
Ondansetron16$259$16
Warfarin16$209$13
Tamsulosin11$164$15

2015: 5 drugs

Part D drugs prescribed in 2015
Ondansetron22$769$35
Hydroxyurea12$314$26
Klor-Con M2020$297$15
Dexamethasone11$200$18
Gabapentin12$189$16

Money from drug and device companies

$54 in 2025

Industry payments by year
202522None$54
20241020None$576
20232342None$945
202222None$44

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AbbvieImbruvica$28
1 payment
  • Meals for Imbruvica · 2025-12-04 · $28
Merck Sharp & DohmeKeytruda$26
1 payment
  • Education for Keytruda · 2025-12-09 · $26
See all 2 published payments
Every published payment
Merck Sharp & DohmeEducation · 2025-12-09Keytruda$26
AbbvieMeals · 2025-12-04Imbruvica$28
See earlier years (2024, 2023, 2022)

2024: $576

Payments by company in 2024
Daiichi SankyoEnhertu$140
6 payments
  • Meals for Enhertu · 2024-11-14 · $10
  • Education for Enhertu · 2024-11-14 · $75
  • Meals for Enhertu · 2024-10-17 · $7
  • Meals for Enhertu · 2024-09-05 · $13
  • Meals for Enhertu · 2024-08-27 · $7
  • Meals for Enhertu · 2024-08-08 · $28
Merck Sharp & DohmeKeytruda$83
3 payments
  • Meals for Keytruda · 2024-06-20 · $32
  • Meals for Keytruda · 2024-05-21 · $24
  • Meals for Keytruda · 2024-04-16 · $28
Janssen BiotechDarzalex$83
2 payments
  • Meals for Erleada · 2024-05-06 · $39
  • Meals for Darzalex · 2024-03-19 · $44
Kite PharmaNone$82
1 payment
  • Meals · 2024-10-24 · $82
Coherus BiosciencesUdenyca$51
2 payments
  • Meals for Udenyca · 2024-05-02 · $31
  • Meals for Udenyca · 2024-04-26 · $20
Lilly USAVerzenio$50
2 payments
  • Meals for Verzenio · 2024-05-07 · $25
  • Meals for Verzenio · 2024-03-29 · $26
PfizerInlyta$25
1 payment
  • Meals for Inlyta · 2024-08-29 · $25
CelgeneNone$24
1 payment
  • Meals · 2024-04-09 · $24
Takeda Pharmaceuticals U.S.A.Ninlaro$20
1 payment
  • Meals for Ninlaro · 2024-05-02 · $20
EisaiLenvima$17
1 payment
  • Meals for Lenvima · 2024-03-14 · $17

2023: $945

Payments by company in 2023
Janssen BiotechDarzalex$143
7 payments
  • Meals for Darzalex · 2023-10-05 · $17
  • Meals for Erleada · 2023-08-23 · $16
  • Meals for Imbruvica · 2023-08-17 · $21
  • Meals for Erleada · 2023-06-20 · $16
  • Meals for Darzalex · 2023-04-14 · $34
  • Meals for Imbruvica · 2023-03-21 · $19
  • Meals · 2023-03-18 · $21
Ipsen BiopharmaceuticalsTazverik$114
3 payments
  • Meals for Tazverik · 2023-06-28 · $82
  • Meals for Onivyde · 2023-05-02 · $16
  • Meals for Somatuline Depot · 2023-03-10 · $16
Stemline TherapeuticsOrserdu$76
3 payments
  • Meals for Orserdu · 2023-10-11 · $30
  • Meals for Orserdu · 2023-05-22 · $28
  • Meals for Orserdu · 2023-04-06 · $18
Daiichi SankyoEnhertu$71
3 payments
  • Meals · 2023-11-14 · $29
  • Meals for Enhertu · 2023-10-24 · $14
  • Meals for Enhertu · 2023-10-05 · $28
Coherus BiosciencesUdenyca$57
3 payments
  • Meals for Udenyca · 2023-12-07 · $16
  • Meals for Udenyca · 2023-11-03 · $17
  • Meals for Udenyca · 2023-05-05 · $24
Merck Sharp & DohmeKeytruda$49
2 payments
  • Meals for Keytruda · 2023-11-20 · $32
  • Meals for Keytruda · 2023-06-22 · $16
AstraZeneca Pharmaceuticals LPNone$44
2 payments
  • Meals · 2023-09-26 · $21
  • Meals · 2023-05-12 · $23
EisaiLenvima$41
2 payments
  • Meals for Lenvima · 2023-09-08 · $20
  • Meals for Lenvima · 2023-06-17 · $21
CelgeneReblozyl$40
1 payment
  • Meals for Reblozyl · 2023-12-20 · $40
Lilly USARetevmo$31
2 payments
  • Meals for Retevmo · 2023-07-26 · $17
  • Meals for Retevmo · 2023-02-27 · $15
AmgenNplate$30
2 payments
  • Meals for Nplate · 2023-09-13 · $16
  • Meals for Evenity · 2023-05-23 · $14
Takeda Pharmaceuticals U.S.A.Alunbrig$28
1 payment
  • Meals for Alunbrig · 2023-05-16 · $28
SeagenTukysa$27
1 payment
  • Meals for Tukysa · 2023-04-13 · $27
Boehringer Ingelheim PharmaceuticalsGilotrif$27
1 payment
  • Meals for Gilotrif · 2023-10-10 · $27
Genmab U.S.Epkinly$23
1 payment
  • Meals for Epkinly · 2023-09-29 · $23
PharmaEssentia USABesremi$22
1 payment
  • Meals for Besremi · 2023-10-05 · $22
Puma BiotechnologyNone$21
1 payment
  • Meals · 2023-06-09 · $21
TerSera TherapeuticsXermelo$19
1 payment
  • Meals for Xermelo · 2023-04-28 · $19
Bayer Healthcare PharmaceuticalsNubeqa$19
1 payment
  • Meals for Nubeqa · 2023-05-23 · $19
ImmunoGenElahere$17
1 payment
  • Meals for Elahere · 2023-05-20 · $17
GE HealthCareNone$16
1 payment
  • Meals · 2023-08-16 · $16
PfizerIbrance$16
1 payment
  • Meals for Ibrance · 2023-07-25 · $16
Agios PharmaceuticalsPyrukynd$15
1 payment
  • Meals for Pyrukynd · 2023-06-25 · $15

2022: $44

Payments by company in 2022
AstraZeneca Pharmaceuticals LPNone$23
1 payment
  • Meals · 2022-11-07 · $23
Bayer HealthCare PharmaceuticalsXofigo$20
1 payment
  • Meals for Xofigo · 2022-12-07 · $20

Professional record

NPI
1679914501
Licence
CA 95021375, MD R181999
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Nurse practitioner (363L00000X); Federal specialty code 363LA2200X (363LA2200X); Federal specialty code 363LF0000X (363LF0000X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2013-07-08
NPI last updated
2025-12-30
NPI record certified
2025-12-30

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 10710 N Torrey Pines Rd, La Jolla, CA, 92037 · 5725 W Las Positas Blvd Ste 100, Pleasanton, CA, 94588